TrialDiabetes, obesity & metabolism2018

A randomized clinical trial of the efficacy and safety of sitagliptin compared with dapagliflozin in patients with type 2 diabetes mellitus and mild renal insufficiency: The CompoSIT-R study.

Russell Scott et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.